Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2014 Jan 8;7(2):143–156. doi: 10.1016/j.jcmg.2013.09.019

Figure 2. Diagram Showing the Prevalence of any HE and “Diffuse” Global HE Among Patients With Hypertensive LVH and Suspected Cardiac Amyloidosis.

Figure 2

Findings in the subgroup with documented extracardiac amyloidosis are also shown. HE = hyperenhancement; LVH = left ventricular hypertrophy.